Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health

BMC Microbiology

Volumn 17, Issue 1, 2017, Pages

  Khan, Asad U ^a   Maryam, Lubna ^a   Zarrilli, Raffaele ^b,c  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Antibiotic resistance; Carbapenemases; Enterobacteriaceae; New Delhi Metallo Beta Lactamases

Indexed keywords

METALLO BETA LACTAMASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE NDM-1; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BIOCHEMICAL ANALYSIS; DIABETIC FOOT; ENTEROBACTERIACEAE; GENE; GENE EXPRESSION; GENE TRANSFER; HEALTH CARE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMONAS; PUBLIC HEALTH; REVIEW; RMTF GENE; BACTERIUM; CHEMISTRY; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; PUBLIC HEALTH;

EID: 85018162548     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-017-1012-8     Document Type: Review

References (108)

1. Woodford N, Ellington MJ. The emergence of antibiotic resistance by mutation. Clin Microbiol Infect. 2007;13:5-18.
2. Gould IM, Bal AM. New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence. 2013;4:185-91.
3. Winkler ML, Bonomo RA. SHV-129: A gateway to global suppressors in the SHV beta-Lactamase Family? Mol Biol Evol. 2016;33:429-41.
4. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20:440-58.
5. Viau R, Frank KM, Jacobs MR, Wilson B, Kaye K, Donskey CJ, Perez F, Endimiani A, Bonomo RA. Intestinal carriage of carbapenemase-producing organisms: current status of surveillance methods. Clin Microbiol Rev. 2016;29:1-27.
6. Bush K, Pannell M, Lock JL, Queenan AM, Jorgensen JH, Lee RM, Lewis JS, Jarrett D. Detection systems for carbapenemase gene identification should include the SME serine carbapenemase. Int J Antimicrob Agents. 2013;41:1-4.
7. Chia JH, Siu LK, Su LH, Lin HS, Kuo AJ, Lee MH, Wu TL. Emergence of carbapenem-resistant Escherichia coli in Taiwan: resistance due to combined CMY-2 production and porin deficiency. J Chemother. 2009;21:621-6.
8. Mojica MF, Bonomo RA. Fast W.B1-Metallo-beta-Lactamases: Where Do We Stand? Curr Drug Targets. 2016;17:1029-50.
9. Aitha M, Moller AJ, Sahu ID, Horitani M, Tierney DL, Crowder MW. Investigating the position of the hairpin loop in New Delhi metallo-beta-lactamase, NDM-1, during catalysis and inhibitor binding. J Inorg Biochem. 2016;156:35-9.
10. Bush K. A resurgence of beta-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens. Int J Antimicrob Agents. 2015;46:483-93.
11. Padhi S. New Delhi metallo-beta-lactamase: a weapon for the newly emerging drug-resistant bacteria. Indian J Med Sci. 2011;65:317-20.
12. Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother. 2011;66:1260-2.
13. Khan AU, Nordman P. Spread of carbapenemase NDM-1 producers: the situation in India and what may be proposed. Scand J Infect Dis. 2012;44:531-5.
14. Williamson DA, Sidjabat HE, Freeman JT, Roberts SA, Silvey A, Woodhouse R, Mowat E, Dyet K, Paterson DL, Blackmore T, Burns A, Heffernan H. Identification and molecular characterisation of New Delhi metallo-beta-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. Int J Antimicrob Agents. 2012;39:529-33.
15. Khan AU, Parvez S. Detection of bla(NDM-4) in Escherichia coli from hospital sewage. J Med Microbiol. 2014;63:1404-6.
16. Köhler T, Michea-Hamzehpour M, Epp SF, Pechere JC. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob Agents Chemother. 1999;43:424-7.
17. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995;39:1211-33.
18. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228-36.
19. Jovcic B, Lepsanovic Z, Suljagic V, Rackov G, Begovic J, Topisirovic L, Kojic M. Emergence of NDM-1 metallo-beta-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob Agents Chemother. 2011;55:3929-31.
20. Khajuria A, Praharaj AK, Kumar M, Grover N. Emergence of NDM-1 in the clinical isolates of Pseudomonas aeruginosa in India. J Clin Diagn Res. 2013;7:1328-31.
21. Choudhury D, Paul D, Ghosh AS, Das Talukdar A, Dutta Choudhury M, Maurya AP, Dhar Chanda D, Chakravarty A, Bhattacharjee A. Effect of single-dose carbapenem exposure on transcriptional expression of blaNDM-1 and mexA in Pseudomonas aeruginosa. J Glob Antimicrob Resist. 2016;7:72-7.
22. Ruppé É, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5:61.
23. Gilbert P, McBain AJ. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev. 2003;16:189-208.
24. Brovedan M, Marchiaro PM, Morán-Barrio J, Revale S, Cameranesi M, Brambilla L, Viale AM, Limansky AS. Draft genome sequence of Acinetobacter bereziniae HPC229, a carbapenem-resistant clinical strain from Argentina harboring blaNDM-1. Genome Announc. 2016;4:pii:e00117-16.
25. Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol. 2010;300:371-9.
26. Martinez-Martinez L, Pascual A, Hernández-Allés S, Alvarez-Díaz D, Suárez AI, Tran J, Benedí VJ, Jacoby GA. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother. 1999;43:1669-73.
27. Wright GD. Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev. 2005;57:1451-70.
28. Hornsey M, Phee L, Wareham DW. A novel variant, NDM-5, of the New Delhi metallo-beta-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother. 2011;55:5952-4.
29. Yang H, Aitha M, Hetrick AM, Richmond TK, Tierney DL, Crowder MW. Mechanistic and spectroscopic studies of metallo-beta-lactamase NDM-1. Biochemistry. 2012;51:3839-47.
30. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect. 2010;16:112-22.
31. Rolain JM, Parola P, Cornaglia G. New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? Clin Microbiol Infect. 2010;16:1699-701.
32. Hu H, Hu Y, Pan Y, Liang H, Wang H, Wang X, et al. Novel plasmid and its variant harboring both a bla(NDM-1) gene and type IV secretion system in clinical isolates of Acinetobacter lwoffii. Antimicrob Agents Chemother. 2012;56:1698-702.
33. Bogaerts P, Verroken A, Jans B, Denis O, Glupczynski Y. Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect Dis. 2010;10:831-2.
34. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597-602.
35. Bonnin RA, Poirel L, Naas T, Pirs M, Seme K, Schrenzel J, Nordmann P. Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe. Clin Microbiol Infect. 2012;18:E362-5.
36. Sahl JW, Del Franco M, Pournaras S, Colman RE, Karah N, Dijkshoorn L, Zarrilli R. Phylogenetic andgenomic diversity in isolates from the globally distributed Acinetobacter baumannii ST25 lineage. Sci Rep. 2015;5:15188.
37. Szmolka A, Nagy B. Multidrug resistant commensal Escherichia coli in animals and its impact for public health. Front Microbiol. 2013;4:258.
38. Wang Y, Wu C, Zhang Q, Qi J, Liu H, Wang Y, et al. Identification of New Delhi metallo-beta-lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS One. 2012;7:e37152.
39. Khan AU, Nordmann P. NDM-1-producing Enterobacter cloacae and Klebsiella pneumoniae from diabetic foot ulcers in India. J Med Microbiol. 2012;61:454-6.
40. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046-54.
41. Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54:969-76.
42. Janvier F, Jeannot K, Tessé S, Robert-Nicoud M, Delacour H, Rapp C, Mérens A. Molecular characterization of blaNDM-1 in a sequence type 235 Pseudomonas aeruginosa isolate from France. Antimicrob Agents Chemother. 2013;57:3408-11.
43. Gamal D, Fernández-Martínez M, Salem D, El-Defrawy I, Montes LÁ, Ocampo-Sosa AA, Martínez-Martínez L. Carbapenem-resistant Klebsiella pneumoniae isolates from Egypt containing blaNDM-1 on IncR plasmids and its association with rmtF. Int J Infect Dis. 2016;43:17-20.
44. Yao X, Doi Y, Zeng L, Lv L, Liu JH. Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis. 2016;16:288-9.
45. Rahman M, Prasad KN, Pathak A, Pati BK, Singh A, Ovejero CM, et al. RmtC and RmtF 16S rRNA Methyltransferase in NDM-1-Producing Pseudomonas aeruginosa. Emerg Infect Dis. 2015;21:2059-62.
46. Kocsis E, Gužvinec M, Butić I, Krešić S, Crnek SŠ, Tambić A, et al. blaNDM-1 carriage on IncR plasmid in Enterobacteriaceae strains. Microb Drug Resist. 2016;22:123-8.
47. Datta S, Mitra S, Chattopadhyay P, Som T, Mukherjee S, Basu S. Spread and exchange of bla NDM-1 in hospitalized neonates: role of mobilizable genetic elements. Eur J Clin Microbiol Infect Dis. 2017;36:255-65.
48. Bontron S, Nordmann P, Poirel L. Transposition of Tn125 encoding the NDM-1 carbapenemase in Acinetobacter baumannii. Antimicrob Agents Chemother. 2016;60:7245-51.
49. Dortet L, Girlich D, Virlouvet AL, Poirel L, Nordmann P, Iorga BI, Naas T. Characterization of BRPMBL, the bleomycin resistance protein associated with the Carbapenemase NDM. Antimicrob Agents Chemother. 2017;61:pii:e02413-16. Print 2017.
50. Cornaglia G, Rossolini GM. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens. Clin Microbiol Infect. 2009;15:218-23.
51. Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2010;2:a000414.
52. Baiden F, Owusu-Agyei S, Webster J, Chandramohan D. The need for new antibiotics. Lancet. 2010;375:637-8.
53. Heddini A, Cars O, Qiang S, Tomson G. Antibiotic resistance in China-a major future challenge. Lancet. 2009;373:30.
54. Thabit AK, Crandon JL, Nicolau DP. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials. Expert Opin Pharmacother. 2015;16:159-77.
55. Marquez-Ortiz RA, Haggerty L, Sim EM, Duarte C, Castro-Cardozo BE, Beltran M, et al. First complete Providencia rettgeri genome sequence, the NDM-1-producing clinical strain RB151. Genome Announc. 2017;5:pii:e01472-16.
56. Shen P, Yi M, Fu Y, Ruan Z, Du X, Yu Y, Xie X. Detection of an Escherichia coli sequence type 167 strain with two tandem copies of blaNDM-1 in the chromosome. J Clin Microbiol. 2016;55:199-205.
57. Livermore DM. Has the era of untreatable infections arrived? J Antimicrob Chemother. 2009;64(Suppl 1):i29-36.
58. Chen Z, Qlu S, Wang Y, Wang Y, Liu S, Wang Z, et al. Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant Acinetobacter baumannii isolates in China. Clin Infect Dis. 2011;52:692-3.
59. Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 2013;4:107-18.
60. Daikos GL, Markogiannakis A, Souli M, Tzouvelekis LS. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective. Expert Rev Anti-Infect Ther. 2012;10:1393-404.
61. Frere JM, Galleni M, Bush K, Dideberg O. Is it necessary to change the classification of {beta}-lactamases? J Antimicrob Chemother. 2005;55:1051-3.
62. Poirel L, Dortet L, Bernabeu S, Nordmann P. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother. 2011;55:5403-7.
63. Wailan AM, Sidjabat HE, Yam WK, Alikhan NF, Petty NK, Sartor AL, et al. Mechanisms involved in acquisition of blaNDM genes by IncA/C2 and IncFIIY plasmids. Antimicrob Agents Chemother. 2016;60:4082-8.
64. Mishra S, Upadhyay S, Sen MR, Maurya AP, Choudhury D, Bhattacharjee A. Genetic acquisition of NDM gene offers sustainability among clinical isolates of Pseudomonas aeruginosa in clinical settings. PLoS One. 2015;10:e0116611.
65. Campos JC, da Silva MJ, dos Santos PR, Barros EM, Pereira Mde O, Seco BM, et al. Characterization of Tn3000, a transposon responsible for blaNDM-1 dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India. Antimicrob Agents Chemother. 2015;59:7387-95.
66. Khan AU, Rehman MT. Role of non-active-site residue Trp-93 in the function and stability of New Delhi Metallo-beta-Lactamase 1. Antimicrob Agents Chemother. 2015;60:356-60.
67. Zhang F, Xie L, Wang X, Han L, Guo X, Ni Y, Qu H, Sun J. Further spread of bla NDM-5 in Enterobacteriaceae via IncX3 Plasmids in Shanghai, China. Front Microbiol. 2016;7:424.
68. An J, Guo L, Zhou L, Ma Y, Luo Y, Tao C, Yang J. NDM-producing Enterobacteriaceae in a Chinese Hospital, 2014-2015: Identification of NDM-producing Citrobacter werkmanii and acquisition of blaNDM-1-carrying plasmid in vivo in a clinical Escherichia coli isolate. J Med Microbiol. 2016;65:1253-9.
69. Tran DN, Tran HH, Matsui M, Suzuki M, Suzuki S, Shibayama K, et al. Emergence of New Delhi metallo-beta-lactamase 1 and other carbapenemase-producing Acinetobacter calcoaceticus-baumannii complex among patients in hospitals in Ha Noi, Viet Nam. Eur J Clin Microbiol Infect Dis. 2017;36:219-25.
70. Both A, Huang J, Kaase M, Hezel J, Wertheimer D, Fenner I, et al. First report of Escherichia coli co-producing NDM-1 and OXA-232. Diagn Microbiol Infect Dis. 2016;86:437-8.
71. Yang RS, Feng Y, Lv XY, Duan JH, Chen J, Fang LX, et al. Emergence of NDM-5 and MCR-1-producing Escherichia coli clone ST648 and ST156 from a single Muscovy Duck (Cairina moschata). Antimicrob Agents Chemother. 2016;60:6899-902.
72. Xie L, Dou Y, Zhou K, Chen Y, Han L, Guo X, Sun J. Coexistence of blaOXA-48 and truncated blaNDM-1 on different plasmids in a Klebsiella pneumoniae isolate in China. Front Microbiol. 2017;8:133.
73. Joshi PR, Acharya M, Kakshapati T, Leungtongkam U, Thummeepak R, Sitthisak S. Co-existence of blaOXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance. Antimicrob Resist Infect Control. 2017;6:21.
74. Papagiannitsis CC, Malli E, Florou Z, Sarrou S, Hrabak J, Mantzarlis K, Zakynthinos E, Petinaki E. Emergence of sequence type 11 Klebsiella pneumoniae coproducing NDM-1 and VIM-1 metallo-β-lactamases in a Greek hospital. Diagn Microbiol Infect Dis. 2016;87:295-7.
75. Paveenkittiporn W, Kerdsin A, Chokngam S, Bunthi C, Sangkitporn S, Gregory CJ. Emergence of plasmid-mediated colistin resistance and New Delhi metallo-β-lactamase genes in extensively drug-resistant Escherichia coli isolated from a patient in Thailand. Diagn Microbiol Infect Dis. 2017;87:157-9.
76. Zhong LL, Zhang YF, Doi Y, Huang X, Zhang XF, Zeng KJ, et al. Coproduction of MCR-1 and NDM-1 by colistin-resistant Escherichia coli isolated from a healthy individual. Antimicrob Agents Chemother. 2017;61:pii:e01962-16.
77. Zheng B, Dong H, Xu H, Lv J, Zhang J, Jiang X, Du Y, Xiao Y, Li L. Coexistence of MCR-1 and NDM-1 in clinical isolates. Clin Infect Dis. 2016;63:1393-5.
78. Kapmaz M, Erdem F, Abulaila A, Yeniaras E, Oncul O, Aktas Z. First detection of NDM-1 with CTX-M-9, TEM, SHV and rmtC in Escherichia coli ST471 carrying IncI2, A/C and Y plasmids from clinical isolates in Turkey. J Glob Antimicrob Resist. 2016;7:152-3.
79. Lv J, Qi X, Zhang D, Zheng Z, Chen Y, Guo Y, et al. First Report of Complete Sequence of a blaNDM-13-harboring plasmid from an Escherichia coli ST5138 clinical isolate. Front Cell Infect Microbiol. 2016;6:130.
80. Quan J, Li X, Chen Y, Jiang Y, Zhou Z, Zhang H, Sun L, Ruan Z, Feng Y, Akova M, Yu Y. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study. Lancet Infect Dis. 2017;17:400-10.
81. Lázaro-Perona F, Sarria-Visa A, Ruiz-Carrascoso G, Mingorance J, García-Rodríguez J, Gómez-Gil R. Klebsiella pneumoniae co-producing NDM-7 and OXA-48 carbapenemases isolated from a patient with prolonged hospitalisation. Int J Antimicrob Agents. 2016;49:112-3.
82. Lai CC, Chuang YC, Chen CC, Tang HJ. Coexistence of MCR-1 and NDM-9 in a clinical carbapenem-resistant Escherichia coli isolate. Int J Antimicrob Agents. 2017;49:517-8.
83. Liu BT, Song FJ, Zou M, Hao ZH, Shan H. Emergence of colistin resistance gene mcr-1 in Cronobacter sakazakii producing NDM-9 and in Escherichia coli from the same animal. Antimicrob Agents Chemother. 2017;61:pii: e02347-16.
84. Du H, Chen L, Chavda KD, Pandey R, Zhang H, Xie X, Tang YW, Kreiswirth BN. Genomic characterization of Enterobacter cloacae isolates from China that coproduce KPC-3 and NDM-1 carbapenemases. Antimicrob Agents Chemother. 2016;60:2519-23.
85. Rogers BA, Sidjabat HE, Silvey A, Anderson TL, Perera S, Li J, Paterson DL. Treatment options for New Delhi metallo-beta-lactamase-harboring enterobacteriaceae. Microb Drug Resist. 2013;19:100-3.
86. Tada T, Miyoshi-Akiyama T, Shimada K, Kirikae T. Biochemical analysis of metallo-beta-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan. Antimicrob Agents Chemother. 2014;58:3538-40.
87. Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob Agents Chemother. 2012;56:2184-6.
88. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219-28.
89. Poirel L, Bonnin RA, Nordmann P. Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing. Antimicrob Agents Chemother. 2011;55:4224-9.
90. Dortet L, Nordmann P, Poirel L. Association of the emerging carbapenemase NDM-1 with a bleomycin resistance protein in Enterobacteriaceae and Acinetobacter baumannii. Antimicrob Agents Chemother. 2012;56:1693-7.
91. Gottig S, Hamprecht AG, Christ S, Kempf VA, Wichelhaus TA. Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-beta-lactamase with increased carbapenemase activity. J Antimicrob Chemother. 2013;68:1737-40.
92. Tada T, Miyoshi-Akiyama T, Dahal RK, Sah MK, Ohara H, Kirikae T, Pokhrel BM. NDM-8 metallo-beta-lactamase in a multidrug-resistant Escherichia coli strain isolated in Nepal. Antimicrob Agents Chemother. 2013;57:2394-6.
93. Wang X, Li H, Zhao C, Chen H, Liu J, Wang Z, et al. Novel NDM-9 metallo-beta-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China. Int J Antimicrob Agents. 2014;44:90-1.
94. Khajuria A, Praharaj AK, Kumar M, Grover N. Presence of a novel variant NDM-10, of the New Delhi metallo-beta-lactamase in a Klebsiella pneumoniae isolate. Indian J Med Microbiol. 2016;34:121-3.
95. Tada T, Shrestha B, Miyoshi-Akiyama T, Shimada K, Ohara H, Kirikae T, Pokhrel BM. NDM-12, a novel New Delhi metallo-beta-lactamase variant from a carbapenem-resistant Escherichia coli clinical isolate in Nepal. Antimicrob Agents Chemother. 2014;58:6302-5.
96. Shrestha B, Tada T, Miyoshi-Akiyama T, Shimada K, Ohara H, Kirikae T, Pokhrel BM. Identification of a novel NDM variant, NDM-13, from a multidrug-resistant Escherichia coli clinical isolate in Nepal. Antimicrob Agents Chemother. 2015;59:5847-50.
97. Zou D, Huang Y, Zhao X, Liu W, Dong D, Li H, et al. A novel New Delhi metallo-beta-lactamase variant, NDM-14, isolated in a Chinese Hospital possesses increased enzymatic activity against carbapenems. Antimicrob Agents Chemother. 2015;59:2450-3.
98. Kazmierczak KM, Rabine S, Hackel M, McLaughlin RE, Biedenbach DJ, Bouchillon SK, Sahm DF, Bradford PA. Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-beta-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2016;60:1067-78.
99. Liu Z, Wang Y, Walsh TR, Liu D, Shen Z, Zhang R, et al. Plasmid-mediated novel blaNDM-17 gene encoding a carbapenemase with enhanced activity in a ST48 Escherichia coli strain. Antimicrob Agents Chemother. 2017. [Epub ahead of print].
100. Rahman M, Shukla SK, Prasad KN, Ovejero CM, Pati BK, Tripathi A, et al. Prevalence and molecular characterisation of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug resistant Enterobacteriaceae from India. Int J Antimicrob Agents. 2014;44:30-7.
101. Sidjabat HE, Townell N, Nimmo GR, George NM, Robson J, Vohra R, et al. Dominance of IMP-4-producing Enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia. Antimicrob Agents Chemother. 2015;59:4059-66.
102. Ahmad N, Ali SM, Khan AU. First reported New Delhi metallo-β-lactamase-1- producing Cedecea lapagei. Int J Antimicrob Agents. 2017;49:118-9.
103. Wang Q, Zhang Y, Yao X, Xian H, Liu Y, Li H, et al. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. Eur J Clin Microbiol Infect Dis. 2016;35:1679-89.
104. Albu SA, Koteva K, King AM, Al-Karmi S, Wright GD, Capretta A. Total synthesis of aspergillomarasmine A and related compounds: A sulfamidate approach enables exploration of structure-activity relationships. Angew Chem Int Ed Engl. 2016;55:13259-62.
105. Pan Z, Liu R, Zhang P, Zhou H, Fu Y, Zhou J. Combination of tigecycline and levofloxacin for successful treatment of nosocomial pneumonia caused by New Delhi Metallo-β-Lactamase-1-producing Raoultella planticola. Microb Drug Resist. 2016;23:127-31.
106. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1-12.
107. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, et al. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 2008;36:W465-9.
108. Dereeper A, Audic S, Claverie JM, Blanc G. BLAST-EXPLORER helps you building datasets for phylogenetic analysis. BMC Evol Biol. 2010;10:8.